Renal dysfunction in heart failure and hypervolumenia: Importance of congestion and backward failure;Nierenversagen bei Herzinsuffizienz und Hypervolämie: Bedeutung von Stauung und Rückwärtsversagen

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 109, Issue 4, 2014, Pages 252-256

  Druml, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardio renal syndrome 1; Heart failure; Renal function; Renal insufficiency; Volume overload

Indexed keywords

ALDOSTERONE ANTAGONIST; DIURETIC AGENT; VASOPRESSIN ANTAGONIST;

ARTICLE; CENTRAL VENOUS PRESSURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; FORWARD HEART FAILURE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART OUTPUT; HEART PRELOAD; HUMAN; HYPERVOLEMIA; KIDNEY FAILURE; KIDNEY VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; PERITONEAL DIALYSIS; ULTRAFILTRATION; BLOOD VOLUME; CARDIO-RENAL SYNDROME; HEART; INTENSIVE CARE; KIDNEY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

BLOOD VOLUME; CARDIO-RENAL SYNDROME; HEART; HEART FAILURE; HUMANS; INTENSIVE CARE; KIDNEY; MULTIPLE ORGAN FAILURE;

EID: 84901236457     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-013-0323-2     Document Type: Article

References (44)

1. Anand IS, Ferrari R, Kalra GS et al (1989) Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 80: 299-305.
2. Schrier RW, Masoumi A, Elhassan E (2009) Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome. Blood Purif 27: 28-32.
3. Schrier RW, Masoumi A, Elhassan E (2010) Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome. Clin J Am Soc Nephrol 5: 1132-1140.
4. Schrier RW, Fassett RG, Ohara M, Martin PY (1998) Pathophysiology of renal fluid retention. Kidney Int Suppl 67: S127-S132.
5. Marenzi G, Moltrasio M, Assanelli E et al (2007) Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 153: 755-762.
6. Cowie MR, Komajda M, Murray-Thomas T et al (2006) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27: 1216-1222.
7. Druml W (1998) The heart and kidney. Wien Klin Wochenschr 110: 69-71.
8. Kos T, Pacher R, Wimmer A et al (1998) Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Wien Klin Wochenschr 110: 89-95.
9. Damman K, Valente MA, Voors AA et al (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35: 455-469.
10. Guglin M, Rivero A, Matar F, Garcia M (2011) Renal dysfunction in heart failure is due to congestion but not low output. Clin Cardiol 34: 113-116.
11. Prowle JR, Echeverri JE, Ligabo EV et al (2010) Fluid balance and acute kidney injury. Nat Rev Nephrol 6: 107-115.
12. Prowle JR, Kirwan CJ, Bellomo R (2014) Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 10: 37-47.
13. Gnanaraj J, Haehling S von, Anker SD et al (2013) The relevance of congestion in the cardio-renal syndrome. Kidney Int 83: 384-391.
14. Clerico A, Emdin M (2004) Endocrine paradox in heart failure: resistance to biological effects of cardiac natriuretic hormones. Clin Chem 50: 2465-2467 (author reply 2467-2468).
15. Hasking GJ, Esler MD, Jennings GL et al (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621.
16. Frey B, Pacher R, Locker G et al (2000) Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients. Chest 117: 1713-1719.
17. Druml W, Steltzer H, Waldhausl W et al (1993) Endothelin-1 in adult respiratory distress syndrome. Am Rev Respir Dis 148: 1169-1173.
18. Lueder TG von, Kjekshus H, Edvardsen T et al (2004) Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1. Cardiovasc Res 63: 41-50.
19. Dupuis J, Rouleau JL, Cernacek P (1998) Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction. Circulation 98: 1684-1687.
20. Mabuchi N, Tsutamoto T, Wada A et al (2002) Relationship between interleukin-6 production in the lungs and pulmonary vascular resistance in patients with congestive heart failure. Chest 121: 1195-1202.
21. Jalan R, Forrest EH, Redhead DN et al (1997) Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 40: 664-670.
22. Lang F, Tschernko E, Schulze E et al (1991) Hepatorenal reflex regulating kidney function. Hepatology 14: 590-594.
23. Ming Z, Lautt WW (2006) Caffeine-induced natriuresis and diuresis via blockade of hepatic adenosine-mediated sensory nerves and a hepatorenal reflex. Can J Physiol Pharmacol 88: 1115-1121.
24. Winton FR (1931) The influence of venous pressure on the isolated mammalian kidney. J Physiol 72: 49-61.
25. Firth JD, Raine AE, Ledingham JG (1988) Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1: 1033-1035.
26. Damman K, Deursen VM van, Navis G et al (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53: 582-588.
27. Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 589-596.
28. Stone HH, Fulenwider JT (1977) Renal decapsulation in the prevention of post-ischemic oliguria. Ann Surg 186: 343-355.
29. Mason J, Torhorst J, Welsch J (1984) Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int 26: 283-293.
30. Herrler T, Tischer A, Meyer A et al (2010) The intrinsic renal compartment syndrome: new perspectives in kidney transplantation. Transplantation 89: 40-46.
31. Verbrugge FH, Dupont M, Steels P et al (2013) Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol 62: 485-495.
32. Silva PL, Guldner A, Uhlig C et al (2013) Effects of intravascular volume replacement on lung and kidney function and damage in nonseptic experimental lung injury. Anesthesiology 118: 395-408.
33. Sharma R, Bolger AP, Li W et al (2003) Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 92: 188-193.
34. Sandek A, Bauditz J, Swidsinski A et al (2007) Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50: 1561-1569.
35. Goncalves S, Pecoits-Filho R, Perreto S et al (2006) Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant 21: 2788-2794.
36. Payen D, Pont AC de, Sakr Y et al (2008) A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 12: R74.
37. Ganda A, Onat D, Demmer RT et al (2010) Venous congestion and endothelial cell activation in acute decompensated heart failure. Curr Heart Fail Rep 7: 66-74.
38. Matsue Y, Suzuki M, Seya M et al (2013) Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. J Cardiol 61: 169-174.
39. Massie BM, O'Connor CM, Metra M et al (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363: 1419-1428.
40. Kazory A (2013) Cardiorenal syndrome: ultrafiltration therapy for heart failure - trials and tribulations. Clin J Am Soc Nephrol 8: 1816-1828.
41. Bart BA, Hernandez AF (2012) Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med 368: 1159-1160.
42. Kwong JS, Yu CM (2014) Ultrafiltration for acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol 172: 395-402.
43. Marenzi G, Muratori M, Cosentino ER et al (2014) Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail 20: 9-17.
44. Courivaud C, Kazory A, Crepin T et al (2014) Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Int 34: 100-108.